The 5-year CSS and DFS rates for patients in the high LDLRAD4 expression group were 82.0% and 70.4%, respectively, compared with 46.0% and 38.0% in CRC patients in the low LDLRAD4 expression group (p = 0.031, Fig. 3g; p = 0.035, Fig. 3h). Here, LDLRAD4 is linked to colorectal carcinoma.